Health Care Psychedelics " Clearmind Medicine (CSE:CMND) announces upcoming pre-IND meeting with the FDA Clearmind (CMND) will participate in a pre-IND meeting with the FDA on May 18, 2022. Trevor Abes2 mins13 May 2022 16:15 (EDT)
Psychedelics " Red Light Holland (CSE:TRIP) adds Akwasi Owusu-Bempah to Advisory Board Red Light Holland (TRIP) has hired drug law expert Akwasi Owusu-Bempah as its newest advisor. Trevor Abes2 mins11 May 2022 10:45 (EDT)
Psychedelics " Optimi Health Corp (CSE:OPTI) completes expansion of on-site analytical laboratory Optimi Health (OPTI) has expanded the analytical laboratory at its Princeton, British Columbia facility. Azuka Onwuka2 mins11 May 2022 10:15 (EDT)
Psychedelics " Clearmind Medicine (CSE:CMND) and SciSparc Ltd., collaboration yields new provisional patent application Clearmind Medicine (CMND) filed a provisional patent application resulting from its recently launched collaboration with SciSparc Ltd. (NASDAQ: SPRC). Brieanna McCutcheon3 mins10 May 2022 12:15 (EDT)
Psychedelics " Optimi Health (CSE:OPTI) expands psilocybin production capacity via license amendment Optimi Health Corp. (OPTI) has been granted an amendment to its controlled substances dealer’s licence by Health Canada. Caroline Egan2 mins04 May 2022 14:00 (EDT)
Health Care Market News Psychedelics " Field Trip Health (TSX:FTRP) to spin off into two public companies Field Trip (FTRP) has announced plans to spin off its Field Trip Discovery and Field Trip Health divisions. Trevor Abes3 mins29 April 2022 10:15 (EDT)
Psychedelics " Optimi Health (CSE:OPTI) opens licensed psilocybin cultivation facility Optimi Health (OPTI) is set to open its new psilocybin cultivation facility in British Columbia. Simon Druker2 mins28 April 2022 14:45 (EDT)
Psychedelics " Nirvana (CSE:NIRV) reports progress with dealer’s license application and facility development Nirvana Life Sciences (NIRV) has provided an update to investors regarding the licensing and development application for its Vancouver lab facility. Caroline Egan2 mins26 April 2022 16:15 (EDT)
Psychedelics The Market Herald Deal Room " MYND Life Sciences (CSE:MYND) announces $3.5M non-brokered private placement MYND Life Sciences (MYND) has announced plans to undertake a non-brokered private placement to raise gross proceeds of up to $3,500,000. John Ballem1 min22 April 2022 08:45 (EDT)
Health Care Psychedelics " Nirvana (CSE:NIRV) announces first production of Psilocybin and Psilocin Nirvana Life Sciences Inc. (NIRV) has announced that its supply agreement with Symeres B.V. Azuka Onwuka2 mins21 April 2022 13:00 (EDT)
Health Care Psychedelics Sponsored The Power Play " Psyence (CSE:PSYG) and Filament Health (NEO:FH) sign licensing agreement Psyence (PSYG) and Filament Health (FH) have signed an exclusive licensing agreement. John Ballem2 mins19 April 2022 14:30 (EDT)
Health Care Psychedelics " Irwin Naturals (CSE:IWIN) acquires psychedelic treatment clinics Irwin Naturals (IWIN) has announced an agreement to acquire KHC Capital Group. Trevor Abes2 mins18 April 2022 11:15 (EDT)
Psychedelics " Silo Wellness (CSE:SILO) announces $5,950,000 convertible debentures financing Silo Wellness Inc. (SILO) has announced CAD$5,950,000 financing arrangement with Alpha Blue Ocean. Brieanna McCutcheon3 mins14 April 2022 12:30 (EDT)
Psychedelics " Red Light Holland (CSE:TRIP) sponsors group microdosing concert in the Netherlands Red Light Holland Corp. (TRIP) has announced its sponsorship of a groundbreaking group microdosing concert. Brieanna McCutcheon3 mins13 April 2022 15:00 (EDT)
Psychedelics " Red Light Holland (CSE:TRIP) expands its mushroom farms division with farmland purchase Red Light Holland Corp. (TRIP) has signed a purchase and sales agreement to acquire 100 acres of farmland in Peterborough, Ontario for $1.85M. John Ballem2 mins11 April 2022 09:00 (EDT)
Psychedelics The Market Herald Deal Room " Entheon Biomedical (CSE:ENBI) announces $3M non-brokered private placement Entheon Biomedical (ENBI) is proceeding on a non-brokered private placement financing for gross proceeds of up to $3 million. John Ballem1 min05 April 2022 09:15 (EDT)
Psychedelics " Psyched Wellness (CSE:PSYC) mushroom studies show anti-inflammatory effects Psyched Wellness (PSYC) has shared preliminary data from studies on the neuroprotective properties of the AME-1 extract. Caroline Egan2 mins24 March 2022 12:15 (EDT)
Psychedelics " Red Light Holland (CSE:TRIP) enters Canadian retail space Red Light Holland’s (TRIP) Mushroom Home Grow Kits are now sold in 30 Canadian locations. Trevor Abes1 min22 March 2022 09:45 (EDT)
Psychedelics " Nirvana (CSE:NIRV) progresses psychedelic dealer’s license and facility development Nirvana Life Sciences (NIRV) reports progress with licensing and development of its Vancouver research and development facility. Caroline Egan2 mins21 March 2022 16:00 (EDT)
Psychedelics " Optimi Health (CSE:OPTI) begins cultivation of natural psilocybin for clinical trials Optimi Health (OPTI) has commenced the cultivation of natural GMP-grade psilocybin mushrooms at its Princeton, British Columbia facility. John Ballem2 mins18 March 2022 10:45 (EDT)
